In the BioHarmony Drug Report Database
Goserelin
Zoladex (goserelin) is a protein pharmaceutical. Goserelin was first approved as Zoladex on 1989-12-29. The pharmaceutical is active against gonadotropin-releasing hormone receptor. Zoladex’s patent is valid until 2022-04-13 (FDA).
Trade Name
|
Zoladex |
|---|---|
Common Name
|
goserelin |
ChEMBL ID
|
CHEMBL1201247 |
Indication
|
|
Drug Class
|
Prehormones or hormone-release stimulating peptides |
Image (chem structure or protein)